Wegovy is priced in India based on dosage tiers. The starting doses of 0.25 mg, 0.5 mg, and 1.0 mg are priced at Rs 4,336.25 per week, or Rs 17,345 for four weeks of therapy.

Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA Results from the phase 3b STEP UP trial ...

Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA Results from the phase 3b STEP UP ...

Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA Results from the phase 3b STEP UP trial ...

In the STEP UP trial, the higher dose of Wegovy ® (semaglutide 7.2 mg) demonstrated a mean weight loss of 21%, with a third of participants losing 25% or more of their body weight compared to ...

Session ID: 2025-07-07:bd1c2462ad6cfbf535b3e26 Player Element ID: V19fa5705_57bc_488b_92e3_56d957c21460_6374239220112 ...

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed ...

Key Takeaways HC-7366, a GCN2 activator, combined with Welireg, a HIF-2α inhibitor, completed dose escalation in a phase 1b study for advanced ccRCC. The study identified 40 mg and 60 mg doses of ...

This suggests that Wegovy starts working at the introductory dose of 0.25mg. Participants in the Wegovy trial increased their dose every four weeks until reaching a maintenance dose of 2.4 mg.